Glenmark Life Sciences Ltd.

View in App
822.05 -4.45 ▼-0.5%

25 April 2024, 11:56:59 AM
Volume: 20,308

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.glenmarklifesciences.com
Market Cap 10,130.55 Cr.
Enterprise Value(EV) 9,687.47 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 42.38 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 19.51 Trailing Twelve Months Ending 2023-12
Industry PE 41.30 Trailing Twelve Months Ending 2023-12
Book Value / Share 204.89 Trailing Twelve Months Ending 2023-12
Price to Book Value 4.04 Calculated using Price: 826.80
Dividend Yield 2.54 Period Ending 2023-03
No. of Shares Subscribed 12.25 Cr. 122,527,172 Shares
FaceValue 2
About Glenmark Life Sciences Ltd.
The company is in the business of making high-quality drugs by unlocking the possibilities of science.

Glenmark Life Sciences Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Glenmark Life Sciences Ltd. Performance

View details >>
1 Day
-0.54%
1 Week
+2.76%
1 Month
+9.07%
3 Month
+2.81%
6 Month
+32.79%
1 Year
+76.35%
2 Year
+64.86%
5 Year
10 Year

Glenmark Life Sciences Ltd. Fundamental Ratios

View details >>
6 years 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 0 451.05 127.84 60.91 29.87 22.33
Return on Capital Employed (%) 0 527.74 185.6 96.75 42.24 30.01
Return on Assets (%) -510.59 26.51 19.56 17.82 16.57 15.43

Glenmark Life Sciences Ltd. Balance Sheet

View details >>
Particulars 7 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds -1 88 402 753 2,054 2,138 2,392
Non Curr. Liab. 7 16 23 33 60 62
Curr. Liab. 1 1,380 1,307 1,445 747 1,023 499
Minority Int.
Equity & Liab. 0 1,475 1,726 2,221 2,834 3,220 2,953
Non Curr. Assets 545 565 598 706 852 876
Curr. Assets 0 931 1,160 1,623 2,127 2,369 2,077
Misc. Exp. not W/O
Total Assets 0 1,475 1,726 2,221 2,834 3,220 2,953

Glenmark Life Sciences Ltd. Profit and Loss

View details >>
Particulars 7 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 0 886 1,537 1,885 2,123 2,161 2,368
Other Income 1 12 1 15 29 12
Total Income 0 887 1,549 1,886 2,138 2,190 2,380
Total Expenditure 0 -639 -1,065 -1,294 -1,507 -1,519 -1,629
PBIDT 0 248 484 592 631 671 751
Interest -1 -34 -88 -28 -1 -1
Depreciation -19 -29 -33 -38 -42 -50
Taxation 0 -33 -108 -119 -146 -162 -180
Exceptional Items
PAT 0 196 313 352 419 467 519
Adjusted EPS -8 18 29 33 34 38 42

Glenmark Life Sciences Ltd. Cash Flow

View details >>
Particulars 6 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 10 195 388 598 313
Cash Fr. Inv. -9 -51 -69 -122 -154
Cash Fr. Finan. 0 1 -137 -214 -79 -388
Net Change 0 2 8 106 397 -228
Cash & Cash Eqvt 0 2 10 116 512 284

Glenmark Life Sciences Ltd. Shareholding Pattern

View details >>
9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 82.85 82.85 82.85 82.85 82.85 82.85 82.85 82.85 82.85
Public 17.15 17.15 17.15 17.15 17.15 17.15 17.15 17.15 17.15
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 9.47 9.47 9.47
No. of Shareholders (in Lacs)

Glenmark Life Sciences Ltd. Announcements

View details >>
Wed, 24 Apr 2024
Resignation of Independent director
GLENMARK LIFE SCIENCES LIMITED has informed the Exchange about Resignation of Independent director.
Wed, 24 Apr 2024
Disclosure under SEBI Takeover Regulations
Glenn Saldanha and Glenmark Pharmaceuticals Limitedￂﾠhas Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of Indiaￂﾠ(Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Wed, 24 Apr 2024
Disclosure under SEBI Takeover Regulations
ￂﾠNirma Limitedￂﾠhas Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of Indiaￂﾠ(Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Glenmark Life Sciences Ltd. Technical Scans

View details >>
Wed, 24 Apr 2024
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Increase in 1 Month High Increase in 1 Month
High Increase in 6 Months High Increase in 6 Months
High Increase in 1 Year High Increase in 1 Year
High Increase in 2 Years High Increase in 2 Years

Glenmark Life Sciences Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 360,140.18 1,509.25 +1.6%
Cipla Ltd. 112,292.49 1,397.95 0.0%
Divi's Laboratories Ltd. 101,276.26 3,844.30 +0.8%
Dr. Reddy's Laboratories Ltd. 99,314.42 6,006.65 +0.9%
Mankind Pharma Ltd. 95,586.41 2,397.85 0.0%
Zydus Lifesciences Ltd. 93,730.70 936.15 +0.3%
Torrent Pharmaceuticals Ltd. 90,650.92 2,686.95 +0.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 40.44 1,509.25 +1.6%
Cipla Ltd. Consolidated 2023-12 30.28 1,397.95 0.0%
Divi's Laboratories Ltd. Consolidated 2023-12 73.23 3,844.30 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.00 6,006.65 +0.9%
Mankind Pharma Ltd. Consolidated 2023-12 55.35 2,397.85 0.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 31.52 936.15 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 60.68 2,686.95 +0.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.77 1,509.25 +1.6%
Cipla Ltd. Consolidated 2023-12 4.34 1,397.95 0.0%
Divi's Laboratories Ltd. Consolidated 2023-12 7.77 3,844.30 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.70 6,006.65 +0.9%
Mankind Pharma Ltd. Consolidated 2023-12 10.76 2,397.85 0.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.97 936.15 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.68 2,686.95 +0.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,509.25 +1.6%
Cipla Ltd. Consolidated 2023-03 0.02 1,397.95 0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,844.30 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,006.65 +0.9%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,397.85 0.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 936.15 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,686.95 +0.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,509.25 +1.6%
Cipla Ltd. Consolidated 2023-03 12.85 1,397.95 0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,844.30 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,006.65 +0.9%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,397.85 0.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 936.15 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,686.95 +0.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,509.25 +1.6%
Cipla Ltd. Consolidated 2023-03 12.85 1,397.95 0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,844.30 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,006.65 +0.9%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,397.85 0.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 936.15 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,686.95 +0.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,509.25 +1.6%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,397.95 0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,844.30 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,006.65 +0.9%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,397.85 0.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 936.15 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,686.95 +0.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,509.25 +1.6%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,397.95 0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,844.30 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,006.65 +0.9%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,397.85 0.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 936.15 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,686.95 +0.0%

Glenmark Life Sciences Ltd. FAQ's

What is Glenmark Life Scienc share price?
Can I buy Glenmark Life Scienc shares now?
What is the Dividend Yield of Glenmark Life Scienc?
What is the Market Cap of Glenmark Life Scienc?
What are the key metrics to analyse Glenmark Life Scienc?
What is the 52 Week High and Low of Glenmark Life Scienc?
What is the trend of Glenmark Life Scienc share price?